Cognition-induced modulation of serotonin in the orbitofrontal cortex: A controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [ 18F]altanserin

NeuroImage

Volumn 58, Issue 3, 2011, Pages 905-911

  Hautzel, Hubertus ^a,b   Müller, Hans Wilhelm ^a,b   Herzog, Hans ^c   Grandt, Rüdiger ^a,b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Brain Imaging Center West   (Germany)

Author keywords

Central executive; Decision making; Delayed match to sample; Humans; Neuroimaging; SnPM

Indexed keywords

ALTANSERIN; FLUORINE 18; SEROTONIN; SEROTONIN 2A RECEPTOR;

ADULT; ARTICLE; BRAIN REGION; COGNITION; DECISION MAKING; EXECUTIVE FUNCTION; HUMAN; HUMAN EXPERIMENT; MALE; NEUROIMAGING; NONPARAMETRIC TEST; NORMAL HUMAN; ORBITAL CORTEX; PHOTOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR BINDING; SEROTONINERGIC SYSTEM; TASK PERFORMANCE; VOLUNTEER; WORKING MEMORY;

BRAIN MAPPING; COGNITION; CROSS-OVER STUDIES; FLUORINE RADIOISOTOPES; FRONTAL LOBE; HUMANS; KETANSERIN; MALE; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS;

EID: 80052148146     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.06.009     Document Type: Article

References (67)

1. Aalto S., Hirvonen J., Kaasinen V., Hagelberg N., Kajander J., Nagren K., Seppala T., Rinne J.O., Scheinin H., Hietala J. The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects. Eur.J Nucl. Med. Mol. Imaging 2009, 36:475-483.
2. Alfimova M.V., Monakhov M.V., Abramova L.I., Golubev S.A., Golimbet V.E. Polymorphism of serotonin receptor genes (5-HTR2A) and Dysbindin (DTNBP1) and individual components of short-term verbal memory processes in schizophrenia. Neurosci. Behav. Physiol. 2010, 40:934-940.
3. Allen P.P., Cleare A.J., Lee F., Fusar-Poli P., Tunstall N., Fu C.H., Brammer M.J., McGuire P.K. Effect of acute tryptophan depletion on pre-frontal engagement. Psychopharmacology (Berl) 2006, 187:486-497.
4. Almaguer-Melian W., Cruz-Aguado R., Riva C.L., Kendrick K.M., Frey J.U., Bergado J. Effect of LTP-reinforcing paradigms on neurotransmitter release in the dentate gyrus of young and aged rats. Biochem. Biophys. Res. Commun. 2005, 327:877-883.
5. Brockmann H., Zobel A., Schuhmacher A., Daamen M., Joe A., Biermann K., Schwab S.G., Biersack H.J., Maier W., Boecker H. Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression. J. Psychiatr. Res. 2011, 45:442-451.
6. Brody A.L., Saxena S., Silverman D.H., Alborzian S., Fairbanks L.A., Phelps M.E., Huang S.C., Wu H.M., Maidment K., Baxter L.R. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 1999, 91:127-139.
7. Cabeza R., Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies. J. Cogn. Neurosci. 2000, 12:1-47.
8. Chow T.W., Mamo D.C., Uchida H., Graff-Guerrero A., Houle S., Smith G.S., Pollock B.G., Mulsant B.H. Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults. BMC.Med.Imaging 2009, 9:12.
9. Chudasama Y., Robbins T.W. Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol. Psychol. 2006, 73:19-38.
10. Clarke H.F., Dalley J.W., Crofts H.S., Robbins T.W., Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion. Science 2004, 304:878-880.
11. Curran H.V., Travill R.A. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction 1997, 92:821-831.
12. de Quervain D.J., Henke K., Aerni A., Coluccia D., Wollmer M.A., Hock C., Nitsch R.M., Papassotiropoulos A. A functional genetic variation of the 5-HT2a receptor affects human memory. Nat. Neurosci. 2003, 6:1141-1142.
13. Del-Ben C.M., Deakin J.F., Mckie S., Delvai N.A., Williams S.R., Elliott R., Dolan M., Anderson I.M. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacol. 2005, 30:1724-1734.
14. Dwivedi Y., Pandey G.N. Quantitation of 5HT2A receptor mRNA in human postmortem brain using competitive RT-PCR. NeuroReport 1998, 9:3761-3765.
15. Egan C., Grinde E., DuPre A., Roth B.L., Hake M., Teitler M., Herrick-Davis K. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors. Synapse 2000, 35:144-150.
16. Fontana D.J., Daniels S.E., Henderson C., Eglen R.M., Wong E.H. Ondansetron improves cognitive performance in the Morris water maze spatial navigation task. Psychopharmacol. (Berl) 1995, 120:409-417.
17. Hamacher K., Coenen H.H. No-carrier-added nucleophilic 18F-labelling in an electrochemical cell exemplified by the routine production of [18F]altanserin. Appl. Radiat. Isot. 2006, 64:989-994.
18. Haugbol S., Pinborg L.H., Arfan H.M., Frokjaer V.M., Madsen J., Dyrby T.B., Svarer C., Knudsen G.M. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach. Eur.J Nucl. Med. Mol. Imaging 2007, 34:910-915.
19. Hautzel H., Mottaghy F.M., Schmidt D., Zemb M., Shah N.J., Muller-Gartner H.W., Krause B.J. Topographic segregation and convergence of verbal, object, shape and spatial working memory in humans. Neurosci. Lett. 2002, 323:156-160.
20. Hautzel H., Mottaghy F.M., Specht K., Muller H.W., Krause B.J. Evidence of a modality-dependent role of the cerebellum in working memory? An fMRI study comparing verbal and abstract n-back tasks. NeuroImage 2009, 47:2073-2082.
21. Ichise M., Ballinger J.R. From graphical analysis to multilinear regression analysis of reversible radioligand binding. J Cereb. Blood Flow Metab. 1996, 16:750-752.
22. Ichise M., Ballinger J.R., Vines D., Tsai S., Kung H.F. Simplified quantification and reproducibility studies of dopamine D2-receptor binding with iodine-123-IBF SPECT in healthy subjects. J Nucl. Med. 1997, 38:31-37.
23. Jakala P., Sirvio J., Riekkinen P., Riekkinen P.J. Effects of p-chlorophenylalanine and methysergide on the performance of a working memory task. Pharmacol. Biochem. Behav. 1993, 44:411-418.
24. Knudsen G.M., Svarer C. Neuroreceptor Imaging: Considerations for Design, Data Analysis, and Interpretation 2002, 23-26. Academic Press, San Diego. M. Senda, Y. Kimura, P. Herscovitch (Eds.).
25. Kristiansen H., Elfving B., Plenge P., Pinborg L.H., Gillings N., Knudsen G.M. Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907. Synapse 2005, 58:249-257.
26. Larisch R., Klimke A., Hamacher K., Henning U., Estalji S., Hohlfeld T., Vosberg H., Tosch M., Gaebel W., Coenen H.H., Muller-Gartner H.W. Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man. Behav. Brain Res. 2003, 139:21-29.
27. Lefkowitz R.J., Cotecchia S., Samama P., Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 1993, 14:303-307.
28. Leonhardt S., Gorospe E., Hoffman B.J., Teitler M. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors. Mol. Pharmacol. 1992, 42:328-335.
29. Liy-Salmeron G., Meneses A. Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model. Hippocampus 2008, 18:965-974.
30. Long A.B., Kuhn C.M., Platt M.L. Serotonin shapes risky decision making in monkeys. Soc. Cogn Affect. Neurosci. 2009, 4:346-356.
31. Luciana M., Collins P.F., Depue R.A. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cereb. Cortex 1998, 8:218-226.
32. Luciana M., Burgund E.D., Berman M., Hanson K.L. Effects of tryptophan loading on verbal, spatial and affective working memory functions in healthy adults. J. Psychopharmacol. 2001, 15:219-230.
33. Luttrell L.M., Lefkowitz R.J. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 2002, 115:455-465.
34. Meneses A. Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?. Cell. Mol. Neurobiol. 2002, 22:675-688.
35. Meneses A. Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory. Behav. Brain Res. 2007, 184:81-90.
36. Miller E.K., Cohen J.D. An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 2001, 24:167-202.
37. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002, 15:1-25.
38. Nonkes L.J., Tomson K., Maertin A., Dederen J., Maes J.H., Homberg J. Orbitofrontal cortex and amygdalar over-activity is associated with an inability to use the value of expected outcomes to guide behaviour in serotonin transporter knockout rats. Neurobiol. Learn. Mem. 2010, 94:65-72.
39. Olvera-Cortes M.E., Nguiano-Rodriguez P., Lopez-Vazquez M.A., Alfaro J.M. Serotonin/dopamine interaction in learning. Prog.Brain Res. 2008, 172:567-602.
40. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 1987, 21:123-139.
41. Pinborg L.H., Adams K.H., Svarer C., Holm S., Hasselbalch S.G., Haugbol S., Madsen J., Knudsen G.M. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach. J Cereb. Blood Flow Metab. 2003, 23:985-996.
42. Pinborg L.H., Adams K.H., Yndgaard S., Hasselbalch S.G., Holm S., Kristiansen H., Paulson O.B., Knudsen G.M. [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. J. Cereb. Blood Flow Metab. 2004, 24:1037-1045.
43. Price J.C., Lopresti B.J., Meltzer C.C., Smith G.S., Mason N.S., Huang Y., Holt D.P., Gunn R.N., Mathis C.A. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans. Synapse 2001, 41:11-21.
44. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:676-682.
45. Rao H., Gillihan S.J., Wang J., Korczykowski M., Sankoorikal G.M., Kaercher K.A., Brodkin E.S., Detre J.A., Farah M.J. Genetic variation in serotonin transporter alters resting brain function in healthy individuals. Biol. Psychiatry 2007, 62:600-606.
46. Rose E.J., Simonotto E., Spencer E.P., Ebmeier K.P. The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task. Psychopharmacology (Berl) 2006, 185:339-347.
47. Ruotsalainen S., Sirvio J., Jakala P., Puumala T., MacDonald E., Riekkinen P. Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks. Eur. Neuropsychopharmacol. 1997, 7:99-108.
48. Schmid C.L., Raehal K.M., Bohn L.M. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1079-1084.
49. Schott B.H., Seidenbecher C.I., Richter S., Wustenberg T., bska-Vielhaber G., Schubert H., Heinze H.J., Richardson-Klavehn A., Duzel E. Genetic variation of the serotonin 2a receptor affects hippocampal novelty processing in humans. PLoS.One. 2011, 6:e15984.
50. Sigmund J.C., Vogler C., Huynh K.D., de Quervain D.J., Papassotiropoulos A. Fine-mapping at the HTR2A locus reveals multiple episodic memory-related variants. Biol. Psychol. 2008, 79:239-242.
51. Smith E.E., Jonides J. Storage and executive processes in the frontal lobes. Science 1999, 283:1657-1661.
52. Soloff P.H., Price J.C., Mason N.S., Becker C., Meltzer C.C. Gender, personality, and serotonin-2A receptor binding in healthy subjects. Psychiatry Res. 2010, 181:77-84.
53. Syvalahti E., Penttila J., Majasuo H., Palvimaki E.P., Laakso A., Hietala J. Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain. Pharmacopsychiatry 2006, 39:1-8.
54. Tanaka S.C., Shishida K., Schweighofer N., Okamoto Y., Yamawaki S., Doya K. Serotonin affects association of aversive outcomes to past actions. J. Neurosci. 2009, 29:15669-15674.
55. Terry A.V., Buccafusco J.J., Bartoszyk G.D. Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys. Psychopharmacology (Berl) 2005, 179:725-732.
56. Viviani R., Sim E.J., Lo H., Beschoner P., Osterfeld N., Maier C., Seeringer A., Godoy A.L., Rosa A., Comas D., Kirchheiner J. Baseline brain perfusion and the serotonin transporter promoter polymorphism. Biol. Psychiatry 2010, 67:317-322.
57. Volz K.G., von Cramon D.Y. How the orbitofrontal cortex contributes to decision making-a view from neuroscience. Prog. Brain Res. 2009, 174:61-71.
58. Wadsworth E.J., Moss S.C., Simpson S.A., Smith A.P. SSRIs and cognitive performance in a working sample. Hum. Psychopharmacol. 2005, 20:561-572.
59. Wallis J.D. Orbitofrontal cortex and its contribution to decision-making. Annu. Rev. Neurosci. 2007, 30:31-56.
60. Wallis J.D., Kennerley S.W. Heterogeneous reward signals in prefrontal cortex. Curr. Opin. Neurobiol. 2010, 20:191-198.
61. Wallis J.D., Miller E.K. Neuronal activity in primate dorsolateral and orbital prefrontal cortex during performance of a reward preference task. Eur. J. Neurosci. 2003, 18:2069-2081.
62. Williams G.V., Rao S.G., Goldman-Rakic P.S. The physiological role of 5-HT2A receptors in working memory. J. Neurosci. 2002, 22:2843-2854.
63. Wingen M., Kuypers K.P., Ramaekers J.G. Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI. J. Psychopharmacol. 2007, 21:477-485.
64. Winstanley C.A., Chudasama Y., Dalley J.W., Theobald D.E., Glennon J.C., Robbins T.W. Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology (Berl) 2003, 167:304-314.
65. Wittmann M., Carter O., Hasler F., Cahn B.R., Grimberg U., Spring P., Hell D., Flohr H., Vollenweider F.X. Effects of psilocybin on time perception and temporal control of behaviour in humans. J. Psychopharmacol. 2007, 21:50-64.
66. Zhou F.M., Hablitz J.J. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J. Neurophysiol. 1999, 82:2989-2999.
67. Ziolko S.K., Weissfeld L.A., Klunk W.E., Mathis C.A., Hoge J.A., Lopresti B.J., DeKosky S.T., Price J.C. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease. NeuroImage 2006, 33:94-102.